FREE SHIPPING ON ORDERS OVER $300 – PLUS A FREE GIFT WITH EVERY AUGUST PURCHASE  – THANK YOU FOR YOUR SUPPORT

BPC-157 & TB-500 Blend

SKU BB20 Categories , ,

$140.00

  • Musculoskeletal recovery (tendon, ligament, muscle)

  • Soft‑tissue repair and wound healing

  • Angiogenesis and microvascular support

  • Anti‑inflammatory and cytoprotective pathways

  • Gut‑muscle‑nerve axis modulation (BPC‑157 specific)

  • Fibrosis reduction and improved tissue remodeling

  • Adjunctive interest in orthopedic and soft‑tissue injury models

BPC‑157:

  • Modulates growth‑factor signaling (VEGF, FAK–paxillin pathways)

  • Supports endothelial protection and microvascular stability

  • Influences nitric‑oxide pathways

  • Contributes to gut‑muscle‑nerve axis integrity

  • Exhibits anti‑inflammatory and cytoprotective activity

TB‑500:

  • Enhances cell migration and motility

  • Regulates actin and cytoskeletal organization

  • Promotes angiogenesis and microvascular repair

  • Supports efficient tissue remodeling

Combined Effect: The blend pairs BPC‑157’s endothelial and anti‑inflammatory actions with TB‑500’s actin‑modulating and angiogenic properties, creating a complementary regenerative profile.

Both BPC‑157 and TB‑500 are experimental research peptides. They are not FDA‑approved, and there are no large, controlled human clinical trials confirming safety or efficacy. TB-500 combined with BPC-157 to enhance recovery has been referred to as the “Wolverine Blend” based on the large amount of anecdotal evidence reporting their regenerative support capabilities.  Existing clinical data are primarily from animal studies, in‑vitro research, and the anecdotal reports.

1. Sikiric, P., et al. (2010). Stable gastric pentadecapeptide BPC‑157: novel therapy in gastrointestinal and systemic healing. Current Pharmaceutical Design, 16(10), 1224–1234.
2. Sikiric, P., et al. (2018). BPC‑157 and its effects on blood vessels, angiogenesis, and endothelial protection. Vascular Pharmacology, 111, 56–66.
3. Chang, C. H., et al. (2011). BPC‑157 accelerates tendon‑to‑bone healing in rotator cuff repair. Journal of Orthopaedic Research, 29(3), 437–443.
5. Seiwerth, S., et al. (2014). BPC‑157 and the gut‑brain axis: systemic healing effects. Journal of Physiology and Pharmacology, 65(5), 613–621.
6. Goldstein, A. L., Hannappel, E., & Kleinman, H. K. (2005). Thymosin β4: a multifunctional regenerative peptide. Annals of the New York Academy of Sciences, 1056, 87–98.
7. Malinda, K. M., et al. (1999). Thymosin β4 stimulates directional migration of endothelial cells. FASEB Journal, 13(14), 2311–2312.
8. Philp, D., et al. (2003). Thymosin β4 promotes wound repair by enhancing keratinocyte migration and angiogenesis. Journal of Investigative Dermatology, 121(5), 1106–1116.
9. Bock‑Marquette, I., et al. (2004). Thymosin β4 activates integrin‑linked kinase and promotes cardiac repair. Nature, 432(7016), 466–472.
10. Crockford, D., et al. (2010). Thymosin β4: structure, function, and therapeutic potential. Expert Opinion on Biological Therapy, 10(6), 893–903.

CURRENT BATCH LOT NUMBER: BB202026-05-04

CERTIFICATE OF ANALYSIS – TGMPURE BPC-157/TB500 BLEND 20 MG (BB202026-05-04)

full product description

A BPC‑157 + TB‑500 blend combines two of the most extensively researched regenerative peptides:

  • BPC‑157 (Body Protection Compound-157), a 15‑amino‑acid fragment derived from gastric “Body Protection Compound,” known for its effects on angiogenesis, tendon repair, gut integrity, and anti‑inflammatory signaling.
  • TB‑500, a synthetic fragment of Thymosin Beta‑4, recognized for its ability to enhance cell migration, promote actin regulation, and accelerate wound healing.

Together, these peptides target complementary pathways involved in tissue repair. BPC‑157 primarily modulates growth factor signaling (VEGF, FAK‑paxillin pathways), protects endothelial function, and supports gut‑muscle‑nerve axis healing. TB‑500 enhances angiogenesis, cell motility, and cytoskeletal organization, enabling efficient tissue remodeling.

Modern research (2010s–2020s) suggests that combining these mechanisms may produce synergistic effects in musculoskeletal recovery, soft‑tissue repair, and inflammation control. While both peptides remain experimental and are not FDA‑approved, their complementary actions make the blend a leading candidate in regenerative‑medicine research.

A BPC‑157 + TB‑500 blend offers a complementary regenerative profile—combining BPC‑157’s endothelial and anti‑inflammatory effects with TB‑500’s actin‑modulating and angiogenic properties—to support comprehensive tissue repair.

QUANTITY: 20 MG (10 MG BPC + 10 MG TB-500)

Join Waitlist We will inform you when the product arrives in stock. Please leave your valid email address below.